Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 760-menstrual-and-other-female-reproductive-system-disorders-with-cc-mcc
    Ask Trek AI about this page

    Menstrual and Other Female Reproductive System Disorders with CC/MCC: Inpatient Reimbursement Overview

    DRG 760 encompasses inpatient admissions for menstrual and other female reproductive system disorders with at least one Complication or Comorbidity or Major Complication or Comorbidity, covering conditions such as significant gynecologic hemorrhage, severe dysmenorrhea with complications, and other reproductive tract disorders requiring hospital care. This Diagnosis-Related Group is important for inpatient reimbursement because the Complication or Comorbidity and Major Complication or Comorbidity status influences Medicare payment levels and reflects increased resource use.

    Customize your policy alerts

    Sign up for drg 760 policy alerts

    Get alerted when payer policies referencing 760 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 760 Overview

    DRG 760 covers hospital admissions for menstrual and other female reproductive system disorders when accompanied by at least one Complication or Comorbidity or Major Complication or Comorbidity. Typical cases include significant gynecologic bleeding, severe pelvic pain with associated comorbid conditions, and other disorders requiring inpatient management and possible surgical or medical interventions. This Diagnosis-Related Group matters for Medicare payment because the presence of Complication or Comorbidity or Major Complication or Comorbidity elevates payment relative to non-Complication or Comorbidity cases and affects resource intensity and payment tiering under Medicare rules. Accurate coding of principal and secondary diagnoses is therefore essential to align reimbursement with clinical complexity.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute procedural and perioperative management studies: randomized or observational trials evaluating techniques, timing, and perioperative care for surgical interventions common in this DRG population (for example, endometrial ablation, hysteroscopy with polypectomy, or urgent gynecologic procedures for hemorrhage). These studies enroll hospitalized reproductive‑age and perimenopausal patients presenting with acute bleeding, severe pain, or complications of benign reproductive disorders to compare blood loss control, transfusion rates, perioperative complications, and length of stay. Evidence from this type of research informs inpatient clinical pathways, resource utilization, and coding/DRG optimization for providers and payers by identifying approaches that reduce complications and shorter hospitalization.
    • Comparative effectiveness trials of medical versus procedural management: pragmatic trials or large observational cohorts comparing pharmacologic therapies (for example, hormonal regimens or antifibrinolytics) against minimally invasive procedures for symptomatic menorrhagia or other benign reproductive disorders with comorbid conditions (CC/MCC). These studies focus on patients with significant comorbidity (anemia, bleeding disorders, anticoagulation) or contraindications to surgery to determine symptom control, need for subsequent inpatient admission, readmission rates, and health‑related quality of life. Results are relevant to payers and hospitals in guiding care pathways, reimbursement decisions, and preauthorization policies by clarifying which patients benefit from inpatient versus outpatient management.
    • Post‑discharge outcomes, utilization, and readmission prevention research: cohort studies and quality‑improvement trials examining post‑hospital outcomes such as 30‑ and 90‑day readmissions, transfusion dependence, outpatient follow‑up adherence, and functional recovery among patients discharged after inpatient treatment for menstrual and other reproductive system disorders with CC/MCC. These investigations include diverse populations with social determinants that affect recovery (older reproductive‑age women, those with chronic medical comorbidities, or limited outpatient access) to identify predictors of costly readmissions and opportunities for transitional care interventions. Findings help providers and payers design discharge planning, case management, and bundled payment strategies to reduce avoidable resource use and improve value for this DRG.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.